Express Pharma - Express Pharma

Revenues of ICRA’s sample set to grow by 7-9 per cent in FY2024; OPM to stabilise at 20.5-21.5 per cent in FY2024

It will enable ART centres/clinics to implement the requirements of the Assisted Reproductive Technology Regulations, 2021 for…

The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted…

CMOs showed an increasing reluctance to take on debt in 2022. Even still, large CMOs made acquisitions of companies and facilities…

This collaboration aims to accelerate the application and adoption of DTx in cardiology in India

YESAFILI is intended for the treatment of neovascular age-related macular degeneration, visual impairment due to macular oedema…

Upon completion of the merger, which is subject to approval by Neurogene and Neoleukin stockholders, the combined company is…

New WHO and UNICEF data show promising signs of immunisation services rebounding in some countries, but, particularly in…

The companies plan to make Beyfortus available in the United States ahead of the upcoming RSV season, Sanofi said, adding that it…

Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two…